European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026

Submitted by Anonymous (not verified) on 30 June 2026 - 12:30

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026

Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 30 June 2026 - 12:09

Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 30 June 2026 - 12:00

Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)

Submitted by Anonymous (not verified) on 30 June 2026 - 11:59

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 30 June 2026 - 11:58

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 15:00 (CEST) to 12 May 2026, 16:00 (CEST)

Submitted by Anonymous (not verified) on 30 June 2026 - 11:57

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 15:00 (CEST) to 12 May 2026, 16:00 (CEST)

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 30 June 2026 - 11:36

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 14, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness